Pfizer

 
Leadership development
Leadership development
Ensuring continuity of qualified people moving through and within an organisation is crucial to ensuring a business can keep operating smoothly....
Anger over drug access in TB trial
Anger over drug access in TB trial
Health activists in the United States and South Africa are crying foul about a drug that was tested in South Africa, Zambia, Botswana and Zimbabwe,...
Viagra sells online as hard-up Pfizer tackles counterfeits
Viagra sells online as hard-up Pfizer tackles counterfeits
Men still will need a prescription to buy the blue, diamond-shaped pill on viagra.com, but they no longer have to face a pharmacist to get...
It's war on tropical diseases
It's war on tropical diseases
The heads of 13 of the world's biggest drug companies, brought together by Bill Gates, one of the world's richest men, have agreed to donate more...
A squirt in the right direction for drugmakers?
A squirt in the right direction for drugmakers?
Drugmakers' traditional model is under threat from looming loss of exclusivity on some of the industry's biggest sellers and companies are keen to...
Pfizer to buy Wyeth, will cut jobs
Pfizer to buy Wyeth, will cut jobs
Pfizer Inc is buying rival drug maker Wyeth in a $68-billion deal that will increase its revenue by 50 percent, solidify its No 1 rank in the...
Pfizer nears $68bn deal to buy Wyeth, say sources
Pfizer nears $68bn deal to buy Wyeth, say sources
Pfizer Inc, the No 1 drug maker, was close to a $68-billion purchase of United States rival Wyeth in a move to diversify its revenue base, sources...
Merrill Lynch chief plans exit strategy
Merrill Lynch chief plans exit strategy
The head of the Wall Street investment bank Merrill Lynch was on Monday night negotiating a severance package tipped to be as high as $159-million...
WHO bridges rich-poor intellectual property split
WHO bridges rich-poor intellectual property split
The World Health Organisation's 193 member states on Saturday overcame their deep divisions over intellectual property rules and endorsed a...
Pfizer faces $8,5-billion suit over Nigeria drug trial
Pfizer faces $8,5-billion suit over Nigeria drug trial
A court case brought by Nigeria against Pfizer resumes on Tuesday with the United States drug maker saying it answered a call for help to save the...

Client Media Releases

NWU hosts UNESCO Chair on Multimodal Learning, OER
ITWeb to host training at GDPR Update 2018
Snupit reaches milestone
Rosebank College Polokwane helps matrics
Trade war: emerging markets in the firing line